Advertisement

Journal of Immigrant and Minority Health

, Volume 21, Issue 6, pp 1334–1341 | Cite as

Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes

  • Sara BaghikarEmail author
  • Amanda Benitez
  • Patricia Fernandez Piñeros
  • Yue Gao
  • Arshiya A. Baig
Original Paper

Abstract

Mexican-Americans carry a high burden of type 2 diabetes and are disproportionately affected by diabetes related mortality and morbidity. Poor adherence to medication is an important barrier to achieving metabolic control and contributes to adverse health outcomes and health disparities. Little is known about barriers and facilitators to medication adherence among Mexican-Americans with diabetes. This is a qualitative study of semi-structured interviews with a sample of 27 adults (25 Mexican-Americans and 2 Latinos of other origin) with self-reported type 2 diabetes who were recruited as part of a church-based, randomized controlled trial for diabetes self-management education in a low-income, immigrant neighborhood of Chicago. Face-to-face, in-depth interviews were conducted (one in English and 26 in Spanish), audio-recorded, transcribed verbatim, and professionally translated. Systematic qualitative methods were used to analyze interviews. All 27 participants were Latino, and 25 were of Mexican descent. Participants’ mean age was 57 years, 81% were female, 69% had an annual income less than $20,000 and 48% had no health insurance. Mean A1C level was 8.6% and mean systolic blood pressure was 125 mmHg. The majority of participants (85%) reported using oral diabetes medication and 35% reported taking insulin. 76% reported being affiliated with one of the two partnering catholic churches based in the South Lawndale neighborhood of Chicago, also known as Little Village. Concerns regarding effectiveness and negative impact of diabetes medication were prevalent and expressed by 13 (48%) of 27 participants. Dissatisfaction with ineffective provider communication and not being able to pay for medication were other important barriers to adherence and were expressed by 7% and 11% of participants, respectively. Family support, for example, family members assisting in organizing medications in boxes and reminding participants to take them, was reported by 15% of participants and emerged as an important facilitator to medication adherence. There is a gap in research on factors influencing adherence to diabetes medication among Mexican-Americans. Our study suggests that concerns regarding negative impact of diabetes medication and concerns regarding effectiveness are prevalent barriers to adherence. These barriers can be addressed through educational efforts targeting patients and clinicians by specifically including content on beliefs that lead to poor adherence in diabetes self-management interventions for patients and continuing medical education for providers and by developing interventions that engage family members as a support system for medication adherence.

Keywords

Mexican-Americans Diabetes Medication adherence 

Notes

Supplementary material

10903_2019_867_MOESM1_ESM.pdf (189 kb)
Supplementary material 1 (PDF 189 KB)

References

  1. 1.
    Centers for Disease Control and Prevention. Diabetes report card 2012. Atlanta: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012.Google Scholar
  2. 2.
    Saydah S, Cowie C, Eberhardt MS, De Rekeneire N, Narayan KM. Racemand ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethnic Dis. 2007;17(3):529–35.Google Scholar
  3. 3.
    Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013;13(6):814–23.CrossRefGoogle Scholar
  4. 4.
    Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, et al. Medication nonadherence in diabetes. longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533–9.CrossRefGoogle Scholar
  5. 5.
    Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2005;27:1218–24.CrossRefGoogle Scholar
  6. 6.
    Guillausseau PJ. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab. 2003;29. 78–91.CrossRefGoogle Scholar
  7. 7.
    Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800–5.CrossRefGoogle Scholar
  8. 8.
    Hepke KL, Martus MT, Share DA. Costs and utilization with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10:144–51.PubMedGoogle Scholar
  9. 9.
    Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press; 2003.Google Scholar
  10. 10.
    Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med 2007;167: 1853–1860.CrossRefGoogle Scholar
  11. 11.
    Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33:1014–29.CrossRefGoogle Scholar
  12. 12.
    Peeters B, Van Tongelen I, Boussery K, Mehuys E, Remon JP, Wilems S. Factors associated with medication adherence to oral hypoglycemic agents in different ethnic groups: a systematic literature review and suggestions for further research. Diabet Med. 2011;28:262–75.PubMedGoogle Scholar
  13. 13.
    Venturini F, Nichol MB, Sung JCY, et al. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother. 1999;33:281–88.CrossRefGoogle Scholar
  14. 14.
    Kuo YF, Raji MA, Markides KS, et al. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period. Diabetes Care. 2003;26:3054–60.CrossRefGoogle Scholar
  15. 15.
    Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med. 2009;32:278–84.CrossRefGoogle Scholar
  16. 16.
    Mohan A, Riley B, Boyington D, Kripalani S. Illustrated medication instructions as a strategy to improve medication management among latinos: a qualitative analysis. J Health Psychol. 2013;18(2):187–97.CrossRefGoogle Scholar
  17. 17.
    Baig AA, Benitez A, Locklin CA, Gao Y, et al. Picture good health: a church-based diabetes self-management intervention among latino adults with diabetes. J Gen Intern Med. 2015;30:1481–90.CrossRefGoogle Scholar
  18. 18.
    Whittemore R, Gail D’Eramo, Melkus, Grey M. Applying the social ecological theory to type 2 diabetes prevention and management. J Community Health Nurs. 2004;21(2):87–99.CrossRefGoogle Scholar
  19. 19.
    Colberg SR, Sigal RJ, Femhall B, American College of Sports Medicine, American Diabetes Association, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33;e147–67.CrossRefGoogle Scholar
  20. 20.
    McGruder HF, Malarcher AM, Antoine TL, Greenlund KJ, Croft JB. Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001. Stroke. 2004;35(7):1557–61.CrossRefGoogle Scholar
  21. 21.
    Crespo CJ, Smit E, Andersen RE, Carter-Pokras O, Ainsworth BE. Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Prev Med. 2000;18(1):46–53.CrossRefGoogle Scholar
  22. 22.
    Centers for Disease. Control and Prevention. U.S. physical activity statistics. 2010. http://apps.nccd.cdc.gov/PASurveillance/DemoCompareResultV.asp?State=0&Cat=4&Year=2008&Go=GO. Accessed November 2016.
  23. 23.
    Glasgow RE, Strycker LA, King DK, et al. Robustness of a computer-assisted diabetes self-management intervention across patient characteristics, healthcare settings, and intervention staff. Am J Manag Care. 2006;12(3):137–45.PubMedGoogle Scholar
  24. 24.
    Wen LK, Shepherd MD, Parchman ML. Family support, diet, and exercise among older Mexican Americans with type 2 diabetes. Diabetes Educ. 2004;30(6):980–93.CrossRefGoogle Scholar
  25. 25.
    Aseltine RH, Sabina A, Barclay G, Graham G. Variation in patient-provider communication by patient’s race and ethnicity, provider type, and continuity in and site of care: an analysis of data from the Connecticut Health Care Survey. SAGE Open Med. 2016;4:1–8.CrossRefGoogle Scholar
  26. 26.
    Zolnierek KB, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–34.CrossRefGoogle Scholar
  27. 27.
    Guénette L, Lauzier S, Guillaumie L, et al. Patient’s beliefs about adherence to oral antidiabetic treatment: a qualitative study. Patient Preference Adherence. 2015;9: 413–420.CrossRefGoogle Scholar
  28. 28.
    Tseng CH, Tierney EF, Gerzoff RB, Dudley RA, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes. Diabetes Care. 2008;31(2):261–6.CrossRefGoogle Scholar
  29. 29.
    Berkowitz S, Seligman H, Choudhry NK. Treat or eat: food insecurity, cost-related medication underuse, and unmet needs. Am J Med. 2014;127:303–10.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Emergency MedicineUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Enlace ChicagoChicagoUSA
  3. 3.Erie Family Health CenterChicagoUSA
  4. 4.Department of MedicineUniversity of ChicagoChicagoUSA

Personalised recommendations